Commissioners of the Commission on Human Medicines
ClosedBody: | Commission on Human Medicines |
---|---|
Appointing Department: | Department of Health and Social Care |
Sector: | Health and Social Care |
Location: | London |
Number of Vacancies: | 11 |
Remuneration: | £325 per meeting |
Time Requirements: | Approximately 22 days per year, including 11 meetings and any ad-hoc meetings based on need. |
Campaign Timeline
-
Competition Launched
28/09/2021
-
Closed for Applications
11/11/2021 at 12:00
-
Panel Sift
03/12/2021
-
Final Interview Date
TBC
-
Announcement
TBC
Assessment Panel
-
Stephen Lightfoot Added 28/09/2021
Panel Chair
Chair of MHRA
-
Professor Sir Munir Pirmohamed Added 28/09/2021
Chair of CHM • Representative of Organisation
-
Rima Makarem Added 28/09/2021
Independent Member
Vacancy Description
The Secretary of State for Health and Social Care is looking to appoint eleven new commissioners to the Commission on Human Medicines. This includes ten specialist posts and one lay member. The Commission on Human Medicines (CHM) was established in October 2005. Its functions are set out in regulation 10 of the Human Medicines Regulations 2012 (as amended).
CHM is responsible for:
• advising on applications for National marketing authorisations and orphan designations (GB) for medicines
• considering further representation against its provisional advice in respect of national marketing authorisation applications
• advising on the need for, and content of, risk management plans for new medicines
• advising on the impact of new safety issues on the balance of risks and benefits of licensed medicines – e.g. adding warnings, restricting or suspending use of a medicine
• advising the MHRA and Health Ministers on changes to legal status of marketing authorisations
Commissioners are required to:
• possess or develop a working knowledge and understanding of the UK medicines regulatory procedures
• attend all scheduled and unscheduled meetings of the CHM (and to be present for the whole meeting)
• consider, comment and contribute by drawing on their individual expertise and judgement, as appropriate, on all agenda items and to assist the CHM to frame clear and unequivocal advice to Ministers in accordance with the CHM’s terms of reference
• be able and prepared to speak on a range of relevant issues and not just on their own areas of specialism
• provide formal and informal advice to Ministers between meetings when required
• contribute to and ensure the CHM’s advice takes account of a wider view of risk and benefit, particularly as it is perceived by patients, carers and other members of the public
Person Specification
To be considered, you must be able to demonstrate that you have the qualities, skills and experience to meet all the essential criteria for appointment.
You will:
• demonstrate the ability to operate effectively on a national expert scientific committee
• be a skilled communicator
• demonstrate the ability to assimilate complex scientific information at short notice
• demonstrate the ability and be prepared to contribute actively to the work of the CHM
In addition, for the ten specialist posts successful candidates should be recognised by their peers and/or be Fellows of the relevant Royal Colleges in one of the following areas:
• immunologist
• neurologist
• infectious disease specialists (2 posts)
• general practice
• a nurse specialist
• toxicologists (2 posts)
• psychiatrist
• an expert in data science with a particular interest in cardiovascular disease
Additional Information
Professor Sir Munir Pirmohamed, Chair to the Commission on Human Medicines
The CHM serves a vital role in public health in the UK, impacting on the lives of almost every person in the country. It is an honour and privilege to serve as Chair: I learn an enormous amount from every meeting, and it is great to work with excellent colleagues, with such a diverse range of expertise, within the CHM and the MHRA. I would certainly recommend applying for the CHM – your expertise will make an enormous difference.
For further information regarding the CHM and the role of commissioner please see the candidate information pack.
Attachments | |
---|---|
![]() |
14.1_Monitoring_form_PDF_version |
![]() |
14.1_Monitoring_form_2021 |
![]() |
CHM info pack Final Extended 28.10.21 |